| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A neonatal death associated with Crimean-Congo hemorrhagic fever (Republic of Kalmykia, Russia, June 2016)
|
Dedkov, Vladimir G.
|
|
2017
|
146 |
C |
p. 146-148
|
article
|
| 2 |
An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening
|
Nelson, Emily V.
|
|
2017
|
146 |
C |
p. 21-27
|
article
|
| 3 |
A pilot study to expand treatment of chronic hepatitis C in resource-limited settings
|
Mathur, Poonam
|
|
2017
|
146 |
C |
p. 184-190
|
article
|
| 4 |
A SCID mouse-human lung xenograft model of varicella-zoster virus infection
|
Wang, Wei
|
|
2017
|
146 |
C |
p. 45-53
|
article
|
| 5 |
Bis(benzofuran–thiazolidinone)s and bis(benzofuran–thiazinanone)s as inhibiting agents for chikungunya virus
|
Hwu, Jih Ru
|
|
2017
|
146 |
C |
p. 96-101
|
article
|
| 6 |
Broad-spectrum non-nucleoside inhibitors for caliciviruses
|
Netzler, Natalie E.
|
|
2017
|
146 |
C |
p. 65-75
|
article
|
| 7 |
Celastrol inhibits hepatitis C virus replication by upregulating heme oxygenase-1 via the JNK MAPK/Nrf2 pathway in human hepatoma cells
|
Tseng, Chin-Kai
|
|
2017
|
146 |
C |
p. 191-200
|
article
|
| 8 |
Cell-line dependent antiviral activity of sofosbuvir against Zika virus
|
Mumtaz, Noreen
|
|
2017
|
146 |
C |
p. 161-163
|
article
|
| 9 |
Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds
|
Toth, Karoly
|
|
2017
|
146 |
C |
p. 121-129
|
article
|
| 10 |
DHEA prevents ribavirin-induced anemia via inhibition of glucose-6-phosphate dehydrogenase
|
Handala, Lynda
|
|
2017
|
146 |
C |
p. 153-160
|
article
|
| 11 |
Evaluation of antiviral activity of piperazine against Chikungunya virus targeting hydrophobic pocket of alphavirus capsid protein
|
Aggarwal, Megha
|
|
2017
|
146 |
C |
p. 102-111
|
article
|
| 12 |
Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus
|
Hamana, Atsushi
|
|
2017
|
146 |
C |
p. 130-138
|
article
|
| 13 |
Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs
|
Shuai, Lei
|
|
2017
|
146 |
C |
p. 36-44
|
article
|
| 14 |
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016
|
Gubareva, Larisa V.
|
|
2017
|
146 |
C |
p. 12-20
|
article
|
| 15 |
Human polyclonal antibodies produced in transchromosomal cattle prevent lethal Zika virus infection and testicular atrophy in mice
|
Stein, Derek R.
|
|
2017
|
146 |
C |
p. 164-173
|
article
|
| 16 |
Identification and characterization of small molecule inhibitors of porcine reproductive and respiratory syndrome virus
|
Evans, Alyssa B.
|
|
2017
|
146 |
C |
p. 28-35
|
article
|
| 17 |
Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus
|
Zivcec, Marko
|
|
2017
|
146 |
C |
p. 112-120
|
article
|
| 18 |
Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing
|
van der Ree, Meike H.
|
|
2017
|
146 |
C |
p. 139-145
|
article
|
| 19 |
Inside Back Cover: Notes to Authors
|
|
|
2017
|
146 |
C |
p. IBC
|
article
|
| 20 |
ISAR News
|
|
|
2017
|
146 |
C |
p. e1-e14
|
article
|
| 21 |
New anionic carbosilane dendrons functionalized with a DO3A ligand at the focal point for the prevention of HIV-1 infection
|
Moreno, Silvia
|
|
2017
|
146 |
C |
p. 54-64
|
article
|
| 22 |
Prelim II: Editorial Board
|
|
|
2017
|
146 |
C |
p. ii
|
article
|
| 23 |
Rapamycin-induced autophagy restricts porcine epidemic diarrhea virus infectivity in porcine intestinal epithelial cells
|
Ko, Seongyeol
|
|
2017
|
146 |
C |
p. 86-95
|
article
|
| 24 |
Recombinant hemagglutinin proteins formulated in a novel PELC/CpG adjuvant for H7N9 subunit vaccine development
|
Chen, Ting-Hsuan
|
|
2017
|
146 |
C |
p. 213-220
|
article
|
| 25 |
Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study
|
Rousseau, Antoine
|
|
2017
|
146 |
C |
p. 205-212
|
article
|
| 26 |
Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice
|
Kamiyama, Naganori
|
|
2017
|
146 |
C |
p. 1-11
|
article
|
| 27 |
Screening of an FDA-approved compound library identifies levosimendan as a novel anti-HIV-1 agent that inhibits viral transcription
|
Hayashi, Tsuyoshi
|
|
2017
|
146 |
C |
p. 76-85
|
article
|
| 28 |
Searching for synergy: Identifying optimal antiviral combination therapy using Hepatitis C virus (HCV) agents in a replicon system
|
Pomeroy, Justin J.
|
|
2017
|
146 |
C |
p. 149-152
|
article
|
| 29 |
STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease
|
Schöne, Tobias
|
|
2017
|
146 |
C |
p. 174-183
|
article
|
| 30 |
The history of rabies in the Western Hemisphere
|
Velasco-Villa, Andres
|
|
2017
|
146 |
C |
p. 221-232
|
article
|
| 31 |
Use of whole genome deep sequencing to define emerging minority variants in virus envelope genes in herpesvirus treated with novel antimicrobial K21
|
Tweedy, Joshua G.
|
|
2017
|
146 |
C |
p. 201-204
|
article
|
Journal description